Goldman Sachs Group Inc. Decreases Holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Goldman Sachs Group Inc. lowered its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 7.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,132,518 shares of the real estate investment trust’s stock after selling 85,644 shares during the quarter. Goldman Sachs Group Inc. owned about 0.49% of Sabra Health Care REIT worth $16,161,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. JPMorgan Chase & Co. raised its holdings in Sabra Health Care REIT by 709.0% during the third quarter. JPMorgan Chase & Co. now owns 13,504,420 shares of the real estate investment trust’s stock worth $188,252,000 after purchasing an additional 11,835,109 shares in the last quarter. Norges Bank purchased a new stake in Sabra Health Care REIT in the fourth quarter valued at $31,605,000. Duff & Phelps Investment Management Co. boosted its stake in Sabra Health Care REIT by 58.8% in the fourth quarter. Duff & Phelps Investment Management Co. now owns 2,101,595 shares of the real estate investment trust’s stock valued at $29,990,000 after acquiring an additional 778,355 shares in the last quarter. APG Asset Management US Inc. grew its holdings in shares of Sabra Health Care REIT by 91.7% during the fourth quarter. APG Asset Management US Inc. now owns 1,592,962 shares of the real estate investment trust’s stock worth $22,732,000 after purchasing an additional 762,002 shares during the last quarter. Finally, American Century Companies Inc. grew its holdings in shares of Sabra Health Care REIT by 41.8% during the third quarter. American Century Companies Inc. now owns 2,109,005 shares of the real estate investment trust’s stock worth $29,400,000 after purchasing an additional 622,133 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Health Care REIT Stock Up 2.0 %

Shares of NASDAQ SBRA opened at $15.12 on Friday. The company has a quick ratio of 4.33, a current ratio of 4.33 and a debt-to-equity ratio of 0.89. The firm has a 50-day moving average price of $14.34 and a 200 day moving average price of $14.10. Sabra Health Care REIT, Inc. has a 52 week low of $11.57 and a 52 week high of $15.12. The stock has a market capitalization of $3.50 billion, a price-to-earnings ratio of 75.60, a price-to-earnings-growth ratio of 2.37 and a beta of 1.22.

Sabra Health Care REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, May 31st. Shareholders of record on Monday, May 20th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 7.94%. The ex-dividend date of this dividend was Friday, May 17th. Sabra Health Care REIT’s dividend payout ratio (DPR) is 600.00%.

Insider Activity

In other Sabra Health Care REIT news, Director Catherine Cusack acquired 7,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 22nd. The shares were acquired at an average cost of $14.43 per share, for a total transaction of $101,010.00. Following the transaction, the director now directly owns 46,385 shares of the company’s stock, valued at $669,335.55. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on SBRA. Wedbush reaffirmed an “outperform” rating and set a $17.00 price target on shares of Sabra Health Care REIT in a research report on Thursday, February 29th. Truist Financial raised their price objective on shares of Sabra Health Care REIT from $15.00 to $16.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, Scotiabank upped their target price on shares of Sabra Health Care REIT from $14.00 to $15.00 and gave the company a “sector perform” rating in a report on Wednesday, May 15th. Six research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $15.79.

Sabra Health Care REIT Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.